α-Synuclein-positive structures in cases with sporadic Alzheimer's disease:: morphology and its relationship to tau aggregation

被引:138
作者
Arai, Y
Yamazaki, M
Mori, O
Muramatsu, H
Asano, G
Katayama, Y
机构
[1] Nippon Med Sch, Dept Internal Med 2, Bunkyo Ku, Tokyo 1138602, Japan
[2] Hatsuishi Hosp, Dept Neurol, Chiba, Japan
[3] Nippon Med Sch, Dept Pathol 2, Tokyo 113, Japan
关键词
alpha-synuclein; Alzheimer's disease; dementia with Lewy bodies; Lewy bodies;
D O I
10.1016/S0006-8993(00)03082-1
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Alzheimer's disease (AD) and Parkinson's disease share common clinical and pathological features. In this study, we examined the relationship between AD pathology and alpha -synuclein aggregation. The frequency and distribution of alpha -synuclein-positive structures were systematically investigated in 27 cases with sporadic AD by alpha -synuclein immuno-histochemistry. Thirteen (48.2%) of 27 cases had various a-synuclein-positive structures as well as Lewy bodies. The frequency and density of senile plaques and neurofibrillary tangles were not significantly different between cases with alpha -synuclein structures and those without. alpha -Synuclein-positive structures were found most frequently in the amygdala. The alpha -synuclein-positive inclusions that are different from Lewy bodies were observed at the highest rate in the hippocampus. The discovery of alpha -synuclein as the constituent of Lewy bodies facilitated the detection of Lewy-related structures even in AD cases with widespread and numerous neurofibrillary tangles. alpha -Synuclein-positive inclusions except for Lewy bodies are exposed, and the distribution of them indicates that Lewy body formation may be influenced by the de,degree of tau aggregation. This study also supports the suggestion that cases with AD pathology can be classified into two groups according to the existence or absence of a-synuclein aggregation. (C) 2001 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:287 / 296
页数:10
相关论文
共 34 条
  • [1] Cellular co-localization of phosphorylated tau- and NACP/α-synuclein-epitopes in Lewy bodies in sporadic Parkinson's disease and in dementia with Lewy bodies
    Arima, K
    Hirai, S
    Sunohara, N
    Aoto, K
    Izumiyama, Y
    Uéda, K
    Ikeda, K
    Kawai, M
    [J]. BRAIN RESEARCH, 1999, 843 (1-2) : 53 - 61
  • [2] Immunoelectron-microscopic demonstration of NACP/α-synuclein-epitopes on the filamentous component of Lewy bodies in Parkinson's disease and in dementia with Lewy bodies
    Arima, K
    Uéda, K
    Sunohara, N
    Hirai, S
    Izumiyama, Y
    Tonozuka-Uehara, H
    Kawai, M
    [J]. BRAIN RESEARCH, 1998, 808 (01) : 93 - 100
  • [3] Baba M, 1998, AM J PATHOL, V152, P879
  • [4] NEUROPATHOLOGICAL STAGING OF ALZHEIMER-RELATED CHANGES
    BRAAK, H
    BRAAK, E
    [J]. ACTA NEUROPATHOLOGICA, 1991, 82 (04) : 239 - 259
  • [5] Neuropathologic evidence that the Lewy body variant of Alzheimer disease represents coexistence of Alzheimer disease and idiopathic Parkinson disease
    Brown, DF
    Dababo, MA
    Bigio, EH
    Risser, RC
    Eagan, KP
    Hladik, CL
    White, CL
    [J]. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1998, 57 (01) : 39 - 46
  • [6] Accelerated in vitro fibril formation by a mutant α-synuclein linked to early-onset Parkinson disease
    Conway, KA
    Harper, JD
    Lansbury, PT
    [J]. NATURE MEDICINE, 1998, 4 (11) : 1318 - 1320
  • [7] HIPPOCAMPAL DEGENERATION DIFFERENTIATES DIFFUSE LEWY BODY DISEASE (DLBD) FROM ALZHEIMERS-DISEASE - LIGHT AND ELECTRON-MICROSCOPIC IMMUNOCYTOCHEMISTRY OF CA2-3 NEURITES SPECIFIC TO DLBD
    DICKSON, DW
    RUAN, D
    CRYSTAL, H
    MARK, MH
    DAVIES, P
    KRESS, Y
    YEN, SH
    [J]. NEUROLOGY, 1991, 41 (09) : 1402 - 1409
  • [8] ESIRI MM, 1997, GREENFIELDS NEUROPAT, V2, P188
  • [9] HANSEN L, 1990, NEUROLOGY, V40, P1
  • [10] Nigral and cortical Lewy bodies and dystrophic nigral neurites in Parkinson's disease and cortical Lewy body disease contain α-synuclein immunoreactivity
    Irizarry, MC
    Growdon, W
    Gomez-Isla, T
    Newell, K
    George, JM
    Clayton, DF
    Hyman, BT
    [J]. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1998, 57 (04) : 334 - 337